GlassScriptPhysician profile
Rebecca E Morris
NPI 1346633393
$1,475.92
in general payments reported to CMS, 2019-2025
17 companies · $96.53 in 2025
The $96.53 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $288 · 2023: $159 · 2024: $933 · 2025: $96.53.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,188.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $581.33 | 2022-2025 | |
| Lilly USA, LLC | $197.52 | 2024 | Kisunla, Amyvid |
| Lundbeck LLC | $90.95 | 2024 | Vyepti, Rexulti |
| Ucb, INC. | $84.46 | 2024 | Nayzilam |
| Mdd US Operations, LLC | $83.70 | 2024-2025 | Gocovri |
| Novartis Pharmaceuticals Corporation | $71.84 | 2024 | |
| Eisai INC. | $58.60 | 2024 | |
| Jazz Pharmaceuticals INC. | $46.73 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.29 | 2024 | Hyqvia |
| Teva Pharmaceuticals USA, INC. | $42.59 | 2024 | Austedo Xr |
| Acadia Pharmaceuticals INC | $33.09 | 2024-2025 | Nuplazid |
| Argenx US, INC. | $24.76 | 2024 | Vyvgart Hytrulo, Vyvgart |
| Allergan, INC. | $24.56 | 2022 | |
| Tanabe Pharma America, INC. | $24.00 | 2024 | |
| Alexion Pharmaceuticals, INC. | $22.57 | 2024 | Ultomiris |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $22.08 | 2024 | Spravato |
| Emd Serono, INC. | $20.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rebecca Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.